IQVIA (IQV) Revenue & Revenue Breakdown
IQVIA Revenue Highlights
Latest Revenue (Y)
$14.98B
Latest Revenue (Q)
$3.81B
Main Segment (Y)
Research And Development Solutions
Main Geography (Y)
Americas
IQVIA Revenue by Period
IQVIA Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $14.98B | 3.98% |
| 2022-12-31 | $14.41B | 3.86% |
| 2021-12-31 | $13.87B | 22.14% |
| 2020-12-31 | $11.36B | 2.44% |
| 2019-12-31 | $11.09B | 6.49% |
| 2018-12-31 | $10.41B | 6.91% |
| 2017-12-31 | $9.74B | 41.60% |
| 2016-12-31 | $6.88B | 19.88% |
| 2015-12-31 | $5.74B | 5.08% |
| 2014-12-31 | $5.46B | 7.07% |
| 2013-12-31 | $5.10B | 4.81% |
| 2012-12-31 | $4.87B | 12.43% |
| 2011-12-31 | $4.33B | 10.29% |
| 2010-12-31 | $3.92B | - |
IQVIA generated $14.98B in revenue during NA 2023, up 3.98% compared to the previous quarter, and up 143.91% compared to the same period a year ago.
IQVIA Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $3.81B | 1.98% |
| 2024-03-31 | $3.74B | -4.32% |
| 2023-12-31 | $3.91B | 4.63% |
| 2023-09-30 | $3.74B | 0.21% |
| 2023-06-30 | $3.73B | 2.08% |
| 2023-03-31 | $3.65B | -2.33% |
| 2022-12-31 | $3.74B | 4.97% |
| 2022-09-30 | $3.56B | 0.59% |
| 2022-06-30 | $3.54B | -0.76% |
| 2022-03-31 | $3.57B | -1.87% |
| 2021-12-31 | $3.64B | 7.23% |
| 2021-09-30 | $3.39B | -1.37% |
| 2021-06-30 | $3.44B | 0.85% |
| 2021-03-31 | $3.41B | 3.37% |
| 2020-12-31 | $3.30B | 18.38% |
| 2020-09-30 | $2.79B | 10.51% |
| 2020-06-30 | $2.52B | -8.46% |
| 2020-03-31 | $2.75B | -4.87% |
| 2019-12-31 | $2.90B | 4.55% |
| 2019-09-30 | $2.77B | 1.06% |
| 2019-06-30 | $2.74B | 2.09% |
| 2019-03-31 | $2.68B | -0.15% |
| 2018-12-31 | $2.69B | 3.62% |
| 2018-09-30 | $2.59B | 1.05% |
| 2018-06-30 | $2.57B | 0.16% |
| 2018-03-31 | $2.56B | -0.54% |
| 2017-12-31 | $2.58B | 4.54% |
| 2017-09-30 | $2.46B | 3.79% |
| 2017-06-30 | $2.38B | 2.28% |
| 2017-03-31 | $2.32B | -0.68% |
| 2016-12-31 | $2.34B | 56.16% |
| 2016-09-30 | $1.50B | -3.57% |
| 2016-06-30 | $1.55B | 4.20% |
| 2016-03-31 | $1.49B | -2.08% |
| 2015-12-31 | $1.52B | 6.81% |
| 2015-09-30 | $1.42B | -1.30% |
| 2015-06-30 | $1.44B | 7.12% |
| 2015-03-31 | $1.35B | -4.50% |
| 2014-12-31 | $1.41B | 0.79% |
| 2014-09-30 | $1.40B | 4.40% |
| 2014-06-30 | $1.34B | 2.54% |
| 2014-03-31 | $1.31B | -5.17% |
| 2013-12-31 | $1.38B | 15.33% |
| 2013-09-30 | $1.20B | -7.71% |
| 2013-06-30 | $1.30B | 5.44% |
| 2013-03-31 | $1.23B | -3.89% |
| 2012-12-31 | $1.28B | 6.59% |
| 2012-09-30 | $1.20B | -2.53% |
| 2012-06-30 | $1.23B | 6.41% |
| 2012-03-31 | $1.16B | - |
IQVIA generated $3.81B in revenue during Q2 2024, up 1.98% compared to the previous quarter, and up 104.44% compared to the same period a year ago.
IQVIA Revenue Breakdown
IQVIA Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Research And Development Solutions | $8.39B | $7.92B | $7.56B | $5.76B | $1.73B |
| Contract Sales And Medical Solutions | $727.00M | $743.00M | $784.00M | $741.00M | $200.00M |
| Technology And Analytics Solutions | $5.86B | $5.75B | $5.53B | $4.86B | $1.54B |
IQVIA's latest annual revenue breakdown by segment (product or service), as of Dec 23: Research And Development Solutions (56.03%), Technology And Analytics Solutions (39.12%), and Contract Sales And Medical Solutions (4.85%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Technology And Analytics Solutions | $1.50B | $1.45B | $1.53B | $1.43B | $1.46B | $1.44B | $1.50B | $1.40B | $1.41B | $1.44B | $1.50B | $1.34B | $1.35B | $1.35B | $1.43B | $1.21B | $1.11B | $1.12B | $415.00M | $369.00M |
| Contract Sales And Medical Solutions | $172.00M | $189.00M | $186.00M | $183.00M | $176.00M | $182.00M | $182.00M | $183.00M | $183.00M | $195.00M | $196.00M | $201.00M | $194.00M | $193.00M | $189.00M | $179.00M | $177.00M | $196.00M | $52.00M | $48.00M |
| Research And Development Solutions | $2.15B | $2.10B | $2.15B | $2.12B | $2.10B | $2.03B | $2.06B | $1.98B | $1.95B | $1.93B | $1.94B | $1.85B | $1.89B | $1.87B | $1.68B | $1.40B | $1.24B | $1.44B | $436.00M | $394.00M |
IQVIA's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Research And Development Solutions (56.29%), Technology And Analytics Solutions (39.20%), and Contract Sales And Medical Solutions (4.51%).
IQVIA Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 |
|---|---|
| Asia Pacific | $2.97B |
| Americas | $7.55B |
| EMEA | $4.46B |
IQVIA's latest annual revenue breakdown by geography, as of Dec 23: Americas (50.40%), EMEA (29.76%), and Asia Pacific (19.84%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 18 |
|---|---|---|---|---|---|
| EMEA | $1.18B | $1.16B | $3.37B | $1.09B | - |
| Americas | $1.86B | $1.80B | $5.70B | $1.86B | $1.17B |
| Asia Pacific | $773.00M | $778.00M | $2.18B | $791.00M | $501.00M |
| Europe And Africa | - | - | - | - | $890.00M |
IQVIA's latest quarterly revenue breakdown by geography, as of Jun 24: Americas (48.85%), EMEA (30.89%), and Asia Pacific (20.27%).
IQVIA Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IQV | IQVIA | $14.98B | $3.81B |
| LH | Laboratory Corporation of America | $12.16B | $3.22B |
| ICLR | ICON Public Limited Company | $8.12B | $2.09B |
| CRL | Charles River Laboratories | $4.13B | $1.03B |
| MTD | Mettler-Toledo | $3.79B | $946.75M |
| IDXX | IDEXX Laboratories | $3.66B | $1.00B |
| WAT | Waters | $2.96B | $708.53M |
| RVTY | Revvity | $2.75B | $691.68M |
| QGEN | Qiagen | $1.97B | $458.80M |
| MEDP | Medpace | $1.89B | $528.10M |
| NEOG | Neogen | $924.22M | $228.81M |
| TWST | Twist Bioscience | $245.11M | $81.46M |
IQV Revenue FAQ
What is IQVIA’s yearly revenue?
IQVIA's yearly revenue for 2023 was $14.98B, representing an increase of 3.98% compared to 2022. The company's yearly revenue for 2022 was $14.41B, representing an increase of 3.86% compared to 2021. IQV's yearly revenue for 2021 was $13.87B, representing an increase of 22.14% compared to 2020.
What is IQVIA’s quarterly revenue?
IQVIA's quarterly revenue for Q2 2024 was $3.81B, a 1.98% increase from the previous quarter (Q1 2024), and a 2.31% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3.74B, a -4.32% decrease from the previous quarter (Q4 2023), and a 2.41% increase year-over-year (Q1 2023). IQV's quarterly revenue for Q4 2023 was $3.91B, a 4.63% increase from the previous quarter (Q3 2023), and a 4.55% increase year-over-year (Q4 2022).
What is IQVIA’s revenue growth rate?
IQVIA's revenue growth rate for the last 3 years (2021-2023) was 8.00%, and for the last 5 years (2019-2023) was 35.14%.
What are IQVIA’s revenue streams?
IQVIA's revenue streams in c 23 are Research And Development Solutions, Contract Sales And Medical Solutions, and Technology And Analytics Solutions. Research And Development Solutions generated $8.4B in revenue, accounting 56.03% of the company's total revenue, up 5.98% year-over-year. Contract Sales And Medical Solutions generated $727M in revenue, accounting 4.85% of the company's total revenue, down -2.15% year-over-year. Technology And Analytics Solutions generated $5.86B in revenue, accounting 39.12% of the company's total revenue, up 2.02% year-over-year.
What is IQVIA’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of IQVIA was Research And Development Solutions. This segment made a revenue of $8.4B, representing 56.03% of the company's total revenue.